Edition:
United Kingdom

People: Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

157.98USD
6:24pm BST
Change (% chg)

$3.26 (+2.11%)
Prev Close
$154.72
Open
$154.90
Day's High
$158.65
Day's Low
$154.79
Volume
29,029
Avg. Vol
99,202
52-wk High
$184.51
52-wk Low
$104.30

Berkman, Charles 

Mr. Charles S. Berkman J.D. is Vice President, General Counsel, Secretary of the Company. He joined the Company in November 2001 and previously served as Associate General Counsel and Chief Patent Counsel for the Company (and Secretary since March 2007). Prior to joining the Company, Mr. Berkman was an attorney at the international law firm of Baker & McKenzie from November 2000 to November 2001. Before that he served as an attorney at the law firm of Lyon & Lyon from 1993 to November 2000, where he specialized in intellectual property law. Mr. Berkman earned a BS in chemistry from the University of Texas and a JD from the University of Texas School of Law.

Basic Compensation

Total Annual Compensation, USD 465,517
Restricted Stock Award, USD 376,275
Long-Term Incentive Plans, USD --
All Other, USD 458,378
Fiscal Year Total, USD 1,300,170

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 30,347 2,076,800.00
Name Fiscal Year Total

John Kozarich

296,271

Matthew Foehr

2,841,260

John Higgins

5,352,640

Matthew Korenberg

1,966,840

Charles Berkman

1,300,170

Nancy Gray

--
As Of  31 Dec 2016